Skip to main content
PLOS One logoLink to PLOS One
. 2023 May 11;18(5):e0285616. doi: 10.1371/journal.pone.0285616

The impact of COVID-19 pandemic on key performance indicators in three Saudi hospitals

Abeer Alharbi 1,*, Ranya S Almana 2, Mohammed Aljuaid 1
Editor: Nasser Hadal Alotaibi3
PMCID: PMC10174493  PMID: 37167286

Abstract

Objective

The coronavirus disease (COVID-19) disrupted healthcare systems and medical care worldwide. This study attempts to assess the performance of three Saudi hospitals during COVID-19 by comparing waiting times for outpatient appointments and the volume of elective surgeries before and after COVID-19.

Methods

We used ADA’A data collected from three Saudi hospitals for this retrospective cohort study. The outcome variables were “Waiting Time for Appointment” and “Elective OR Utilization”. The hospitals included in this study were: a 300-bed maternity and children’s hospital; a 643-bed general hospital; and a 1230-bed tertiary hospital. We included all patients who visited the OPD and OR in the time period from September 2019 to December 2021. A two-way ANOVA test was used to examine the differences in the outcome variables by hospital and by the phase of COVID-19.

Results

For the elective OR utilization rate, the results showed that both the hospital and the phase of COVID-19 were significantly different (p-value < 0.05). On average, the elective OR utilization rate dipped considerably in the early phase of COVID-19 (33.2% vs 44.9%) and jumped sharply in the later phase (50.3%). The results showed that the waiting time for OPD appointment was significantly different across hospitals and before and after COVID-19 in each hospital (p-value < 0.05). the waiting time dropped during the early phase of COVID-19 for both the general hospital (GEN) (24.6 days vs 34.8 days) and the tertiary hospital (MDC) (40.3 days vs 48.6 days), while the maternity and children’s hospital (MCH)’s score deteriorated sharply (24.6 days vs 9.5 days).

Conclusion

This study indicates that COVID-19 led to a significant impact on elective surgery rates and waiting time for OPD appointments in the early stage of the pandemic when the lockdown strategy was implemented in the country. Although the elective surgery rate had decreased at the designated COVID-hospital, the waiting time for OPD appointment had improved. This is a clear indication that the careful planning and management of resources for essential services during pandemic was effective.

Introduction

The coronavirus disease (COVID-19) disrupted healthcare systems and medical care worldwide. The virus was first reported in Wuhan, China, on December 13, 2019. In Saudi Arabia, the first case was confirmed in March 2020 with the number of such cases reaching its peak in June 2020 and fluctuating during July of that year [1]. Then, from August 2020, the number of confirmed cases declined and reached the minimum in February 2021 [1]. From Mar 2 to July 25 in 2020, there have been 262,772 confirmed cases of COVID-19 with 2,672 deaths [2]. In March 8, 2020, the Saudi authorities adopted the lockdown strategy to contain the spread of the disease. They also introduced a range of public health measures consisting of complete and partial curfews, the closure of educational institutions, social distancing, the mandatory use of masks, and the suspension of mass gatherings (like praying in mosques), domestic and international flights, and social and sports events. Hospitals in Saudi Arabia recommended minimizing nonessential visits, especially for children and the more vulnerable persons, to decrease the spread of the virus and to ensure that there was enough capacity to handle the surges in COVID-19 cases. To maximize patient and health worker safety, modifications to service delivery included identifying nonessential health services that could be delayed or canceled in accordance with local or national guidance. Postponing nonessential health services freed health workers to provide COVID-19 care and reduced crowding in waiting rooms. As a result, routine outpatient visits and elective surgeries were postponed [3]. Waiting times for outpatient appointments and the volume of elective surgeries performed were strongly affected by the pandemic [46].

This study attempts to assess the performance of three Saudi hospitals during COVID-19 by comparing waiting times for outpatient appointments and the volume of elective surgeries before and after COVID-19. This was done with a view of helping policymakers to better understand the impact of the pandemic on the healthcare system so they can prepare contingency plans for any such future pandemics. In addition, the inclusion in the study of three hospitals with different scopes of services provided an opportunity to assess the performance in different healthcare settings.

Materials and methods

Data source

We used ADA’A data collected from three Saudi hospitals for this retrospective cohort study. The Ministry of Health (MOH) in Saudi Arabia launched the ADA’A (Performance) program in 2015 to improve the operational performance of the MOH hospitals in Saudi Arabia. The ADA’A program collects several Key Performance Indicators (KPIs) as a means of evaluating the progress of the health system. The KPIs were developed for use by the hospitals to monitor, evaluate, and improve their performing against established benchmarks.

Outcome variables

The KPIs “Waiting Time for Appointment” and “Elective OR Utilization” reflect the performance of the outpatient department (OPD) and the operating room (OR), respectively. “Waiting Time for Appointment” estimates the waiting time (in days) for OPD appointment by specialty, as defined by the third available appointment in OPD per specialty. ADA’A used these following four benchmarks to evaluate this KPI: world Class (less than 14 days), acceptable (14–28 days), need improvement (28–42 days), and unacceptable (more than 42 days). “Elective OR Utilization” estimates the percentage of hours the operation rooms were occupied for elective surgeries within standard hours. The following four benchmarks were used to evaluate this KPI: world class (more than 75%), acceptable (62.5% to 75%), need improvement (50.1% to 62.5%), and unacceptable (<50%). Tables 1 and 2 provide details on the sample size required for the data to be collected, the inclusion and exclusion criteria, and the benchmark classification and target.

Table 1. Data collection/measurement in OPD.

KPI 1: Waiting Time for Appointment (3rd Available Appointment)
Sample size 100%
Calculation Waiting time (in days) for OPD appointment by specialty, as defined by the 3rd available appointment in ODP per specialty. This KPI is measured once per week; the “3rd next available appointment” date is recorded for every specialty. This must be measured on the same day of the week each week, in order to ensure consistency of measurement.
Exclusion Anesthesia clinic (due to scheduling appointments for one week before surgery)
World class Less than 14 days
Acceptable 14–28 days
Need Improvement 28–42 days
Unacceptable More than 42 days

Table 2. Data collection/measurement in OR.

KPI 2: Elective OR Utilization
Sample size 100%
Numerator the sum of hours rooms occupied “wheels in” to “wheels out” within standard working hours
Denominator Sum of hours available (total number of functional rooms* 8 working hours a day* number of working days a week)
Calculation [Numerator/ denominator] × 100
Inclusion Elective surgeries performed within standard hours. Also, surgeries that start within working hours, but overrun
Exclusion All emergency surgeries
World class More than 75%
Acceptable 62.5% to 75%
Need Improvement 50.1% to 62.5%
Unacceptable <50%

Setting

The hospitals included in this study were: a 300-bed maternity and children’s hospital (MCH); a 643-bed general hospital (GEN); and a 1230-bed tertiary hospital (MDC). We used data from all patients who visited the OPD and OR in the time period from September 2019 to December 2021.

Statistical analysis

The data were analyzed using the Statistical Package for Social Sciences (SPSS) program, version 25. A two-way ANOVA test was used to examine the differences in the outcome variables by hospital and by the phase of COVID-19 which was divided into three phases: Pre- COVID (9/2019–2/2020) coded as 0; early-COVID (3/2020–7/2020) coded as 1; and later-COVID (8/2020–12/2021) as 2. A p-value of less than 0.05 was considered to be statistically significant. Effects plots with fitted means and confidence intervals (CI) were used to explain the difference in the outcome variable by hospital and by the phase of COVID-19.

Ethical considerations

The study was reviewed and approved by the Ethics Committee of Scientific Research that supports the King Fahad Medical City Institutional Review Board (KFMD IRB). The committee, on behalf of the Institutional Review Board, approved the research (reference number 22-347E). The need for consent was waived by the ethics committee as we are reporting a retrospective study of quality metrics reports where all data were fully anonymized before accessing them.

Results

The data were collected over 28 months beginning in September of 2019. The elective OR utilization rate and the waiting time for OPD appointment (in days) were plotted by hospital across the 28-month period [Figs 1 and 2]. To examine the differences in the outcome variables by hospital and by the phase of COVID-19, a two-way ANOVA test was used.

Fig 1. The elective OR utilization rate plotted by hospital across the 28-month period.

Fig 1

Fig 2. The waiting time for OPD appointment (in days) plotted by hospital across the 28-month period.

Fig 2

Elective OR utilization rate

For the elective OR utilization rate, the results showed that both the hospital and the phase of COVID-19 were significantly different (p-value < 0.05) [Table 3]. The effects plots tell how they were different [Fig 3]. On average, the elective OR utilization rate dipped considerably in the early phase of COVID-19 (33.2% vs 44.9%) and jumped sharply in the later phase (50.3%). Additionally, the average scores for the maternity and children’s hospital (MCH) (25.5%) were sharply lower than both the general hospital (GEN) and the tertiary hospital (MDC) (55.3%, and 47.5%, respectively). Looking at the interaction plots, the utilization rate dropped during the early phase of COVID-19 for both general hospital (GEN) (44.4% vs 66.6%) and tertiary hospital (MDC) (31.5% vs 49.6%), while the maternity and children’s hospital (MCH) percentages rose slightly (23.7% vs 18.4%). Then in the later phase, GEN, MDC, and MCH all improved their level (54.9%, 61.5, and 34.4%, respectively).

Table 3. Analysis of variance (ANOVA).

Source DF SS MS F P
Elective OR Utilization Rate
Pre/Post-COVID-19 2 0.32 0.16 6.19 0.0033
Hosp. Type 2 1.01 0.50 19.31 <0.001
Interaction 4 0.28 0.07 2.66 0.0391
Error 75 1.95 0.03
Total 83 3.78 0.05
Waiting time for OPD appointment
Pre/Post-COVID-19 2 509.15 254.58 1.01 0.3677
Hosp. Type 2 4742.2 2371.1 9.45 <0.001
Interaction 4 4960.3 1240.1 4.94 0.0014
Error 75 18829 251.06
Total 83 30230 364.22

Fig 3. Effects plots for elective OR utilization rate by hospital and phase of COVID-19.

Fig 3

Waiting time for OPD appointment

The results showed that the waiting time for OPD appointment was significantly different across hospitals and before and after COVID-19 in each hospital (p-value < 0.05) [Table 3]. The effects plots tell how they were different [Fig 4]. The average scores for the maternity and children’s hospital (MCH) (16.7 days) were sharply lower than both the general hospital (GEN) and the tertiary hospital (MDC) (32.9 days, and 36.8 days, respectively). Looking at the interaction plots, the waiting time dropped during the early phase of COVID-19 for both the general hospital (GEN) (24.6 days vs 34.8 days) and the tertiary hospital (MDC) (40.3 days vs 48.6 days), while the maternity and children’s hospital (MCH)’s score deteriorated sharply (24.6 days vs 9.5 days). Then in the later phase, MDC’s score continued to improve by falling further to 21.4 days. Additionally, MCH’s score improved by being lowered to 15.9 days while GEN score deteriorated as it increased to 39.2 days.

Fig 4. Effects Plots for waiting time for OPD appointment (in days) by hospital and phase of COVID-19.

Fig 4

Discussion

For elective surgery rate, the study findings revealed that there was a variation before and after COVID-19. Overall, there was a significant decrease in the elective surgery rate during the early stage of COVID-19. The lower rate of elective surgeries was probably caused by the changes implemented at the Saudi hospitals including postponing elective surgeries in response to the spread of the disease. This is consistent with previous studies which discovered that the rate of elective surgeries was negatively affected by COVID-19 [4, 5]. The study findings also revealed that the performance seemed to vary significantly across hospitals. This was not surprising considering the dissimilarity in the scope of services provided in each of them, the population served, and the complexity of the medical condition. In addition, the general hospital (GEN) was assigned as a COVID-hospital while the other two were not. Looking at the effect of COVID-19 on each hospital, we observed that during the early stage of COVID-19, both the general hospital (GEN) and the tertiary hospital (MDC)’s elective surgery rate had deteriorated. The rate dropped sharply for GEN going from “acceptable” at pre-COVID-19 to “unacceptable” in early COVID-19 stage. In addition, MDC performance dropped by eighteen percentage points in early COVID-19. These drops in elective surgery rates were to be expected as healthcare systems were affected by the pandemic with the surges of COVID-19 cases and the newly implemented guidelines and mitigation precautions implemented by the OR. These changes included decreasing the hospitals utilization to 50%, and in GEN hospital, the majority of the manpower was transferred to critical care units because it was designated as a COVID-19 hospital. In the later stage of COVID-19, however, both GEN and MDC improved their elective surgery rates with the post-lockdown abatement of COVID-19. Nevertheless, MCH’s performance improved in the early stages of COVID-19 as the rate of elective surgeries increased by five percentage points. MCH is a 300-bed maternity and children’s hospital that offers elective surgeries including: Lower Segment Caesarean Section (LSCS), Myomectomy, Dilation and Curettage (D&C), Polypectomy, and Suction Curettage. The increase in the rate of elective surgeries at MCH is consistent with another study that found caesarean sections and facility-based deliveries showed significant increases during COVID-19 [7]. In the later stage of COVID-19, the elective surgery rate continued to improve. Despite the increase in the elective surgery rate, MCH still scored a less than 50 percent utilization rate. The low acuity of patients presenting at the hospital might be the reason why less patients were having elective surgeries as compared to the other two hospitals which accommodated more complex patient conditions.

As for waiting time for OPD appointments, we observed that during the early stage of COVID-19, both general hospital (GEN) and tertiary hospital (MDC)’s performance had improved. The waiting time in days dropped sharply for GEN going from “need improvement” at pre-COVID-19 to “acceptable” in the early COVID-19 stage. In addition, MDC’s waiting times dropped by eight days on average in the early COVID-19 stage, moving up to the “need improvement” category. These drops in waiting times for OPD appointments were to be expected as people were avoiding hospitals during the pandemic and appointments were cancelled for mild cases in response to the spread of the disease. This was particularly true for GEN hospital which became a designated COVID-hospital focusing on critical care only. The total number of OPD visits dropped sharply in the early stage of COVID-19 going from more than 89,000 visits to less than 14,000 [S1 Table]. In MDC, the OPD was shut down completely for 2 weeks from mid-March until end of April and they have initiated a virtual clinic for all specialties, except oncology and chemotherapy, which may explain the drop in OPD waiting times. Similarly, the total number of OPD visits dropped sharply in the early stage of COVID-19 going from around 272,000 visits to less than 26,000. However, MCH’s waiting time in days had increased by 15 days on average. MCH restricted its outpatient appointments for only gynecology and part of these appointments were done through virtual visits. In the later stage of COVID-19, MCH improved its waiting time and GEN increased its average waiting time for OPD appointments with the post-lockdown abatement of COVID-19.

This study had some limitations in that it was conducted in the OR and OPD of a specific geographical area of Saudi Arabia which may affect the generalizability of the study. In addition, due to the study’s retrospective nature, limited information was collected on some areas. We used a database of the quality metrics and not medical charts; therefore, the lack of individual patient characteristics prevented us from performing further analysis as to the possible reasons for the OR utilization rates and OPD waiting times in terms of diagnosis, acuity level, and demographics. Future studies taking these factors in consideration are recommended.

Conclusions

The current study indicates that COVID-19 led to a significant impact on elective surgery rates and waiting time for OPD appointments in the early stage of the pandemic when the lockdown strategy was implemented in the country. The study indicates that the general and tertiary hospitals had a decreased elective surgery rate and waiting time for OPD appointments during the early stage of the pandemic, while the maternity and children’s hospital had an increased elective surgery rate and waiting time for OPD appointments. Although the elective surgery rate had decreased at the designated COVID-hospital, the waiting time for OPD appointment had improved. This is a clear indication that the careful planning and management of resources for essential services during pandemic was effective. These findings have provided a better understanding of the impact of the pandemic on the healthcare system and should allow policymakers to prepare contingency plans for any such future pandemics. A well-planned contingency strategy that relies on the strength of the health system and the competence of health personnel is recommended. The plan should provide timely response that is accomplished through careful resource planning, coordination and monitoring at the national level, community involvement, and epidemiological surveillance. Rapid transformation and careful allocation of resources together with changing working methods in hospitals have the potential to mitigate challenges presented by the pandemic.

Supporting information

S1 Table. Total number of OPD and OR visits in each COVID-19 stage in each hospital.

(DOCX)

S1 Data

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

Initials of the authors who received each award. AA, RM, MA Grant numbers awarded to each author. Funded through the Researcher Supporting Project (RSP2022R481), King Saud University, Riyadh, Saudi Arabia. The full name of each funder. Funded through the Researcher Supporting Project (RSP2022R481), King Saud University, Riyadh, Saudi Arabia. URL of each funder website. https://dsrs.ksu.edu.sa/en Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? NO - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Al-Ahdal MN, Al-Ahdal MN. COVID-19 pandemic in Saudi Arabia: The decline continues. Glob J Infect Dis Clin Res. 2020. Dec 22;6(1):057–9. [Google Scholar]
  • 2.World Health Organization (WHO). Coronavirus (COVID-19) Statistics [Internet]. [cited 2022 Aug 22]. https://covid19.who.int
  • 3.WHO G. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). World Health Organ. 2020;
  • 4.Maiassi N, Xanthopoulou K, Löw U, Seitz B. The Impact of the First COVID-19 Lockdown Period on the Inpatient and Outpatient Volume of a University Based Tertiary Referral Center with Corneal Subspecialization in Germany. Clin Ophthalmol Auckl NZ. 2022. Jun 9;16:1795–805. doi: 10.2147/OPTH.S335551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Uimonen M, Kuitunen I, Paloneva J, Launonen AP, Ponkilainen V, Mattila VM. The impact of the COVID-19 pandemic on waiting times for elective surgery patients: A multicenter study. PLoS ONE. 2021. Jul 6;16(7):e0253875. doi: 10.1371/journal.pone.0253875 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Muschol J, Gissel C. COVID-19 pandemic and waiting times in outpatient specialist care in Germany: an empirical analysis. BMC Health Serv Res. 2021. Oct 11;21:1076. doi: 10.1186/s12913-021-07094-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sevalie S, Youkee D, van Duinen AJ, Bailey E, Bangura T, Mangipudi S, et al. The impact of the COVID-19 pandemic on hospital utilisation in Sierra Leone. BMJ Glob Health. 2021. Oct 1;6(10):e005988. doi: 10.1136/bmjgh-2021-005988 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Nasser Hadal Alotaibi

8 Jan 2023

PONE-D-22-26363The Impact of COVID-19 Pandemic on Key Performance Indicators in Three Saudi HospitalsPLOS ONE

Dear Dr. Alharbi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 22 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Nasser Hadal Alotaibi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Table 1 Data Collection, in the sample size category, the author wrote 100% without stating the number of sample size? Does the 100% is referring to the sample size obtained? Best if the author can state the number of sample obtained in frequency too. The sample size obtained for the study is unclear. Is the bed capacity in the respective hospitals is your actual sample?

2. Table 3 Analysis of Variance; best if the author can limit the decimal point to the two decimal point for standardization in statistic. Please follow journal requirement. If it is not stated, two decimal point is best used to indicate the statistic results.

3. Paragraph for discussion (line 185 - 193) is not needed. Focus your discussion based on the result without stating facts that have been previously discussed earlier in the introduction section.

4. The paper is lacking in critical recommendation on the issue, while the author is pushing for proposed contingency plan? what kind of contingency plan that should be proposed for the pandemic? This might add value to the policy maker. Thus the conclusion seemed lacking in providing concrete ending to what should be done to prevent/ address the issue.

Reviewer #2: A well organized article. The ethical review for the research meets the required standards. The methods of statistical analysis used for the research were sound and the results of the 2 way ANOVA test supported the conclusion of the article. Enough data was provided in the article although it would have been easier to absorb/understand the provided data used for analysis (OPD waiting times in days and Elective OR utilization rates during Pre, early and post pandemic periods) if they were all included in a single table of data extraction. The sizes of figures 1-4 could be increased a bit to provide better visibility for the reader. The article was written intelligibly, with appropriate use of the English language although there unnecessary repetition of facts in the introduction and discussion sections eg ''To contain the spread of the COVID-19 disease, the Saudi government adopted the lockdown strategy''. Adequate explanation of the reasons for variation in the results/findings among the 3 hospitals were give in the discussion section with good interpretation of the findings. The limitations were addressed properly and the conclusion was brief and concise. In general, it was a very interesting and quite unique article as it aims to explore, compare and analyse the differences in pandemic effects on Key performance indicators in 3 hospitals providing very different types of medical care.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mohd Redhuan Dzulkipli

Reviewer #2: Yes: Atinuke Hephzibah Adeyemo

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 May 11;18(5):e0285616. doi: 10.1371/journal.pone.0285616.r002

Author response to Decision Letter 0


16 Jan 2023

Response to Reviewers

Reviewer #1

Thank you so much for your valuable comments. Below are my responses for each point.

1. Table 1 Data Collection, in the sample size category, the author wrote 100% without stating the number of sample size? Does the 100% is referring to the sample size obtained? Best if the author can state the number of sample obtained in frequency too. The sample size obtained for the study is unclear. Is the bed capacity in the respective hospitals is your actual sample?

For our research, we used secondary data from Adaa’ program, collected to measure hospital quality metrics. This data did not report the exact sample size but did explain that for the OPD indicator, the data collectors used 100% of the patient’s data who used the OPD during the study period. Similarly, for the OR indicator, the data collectors used 100% of the patient’s data who used the OR during the study period. However, we added the visits numbers for the OPD and OR during the study three stages (pre-COVID, early-COVID, and post-COVID) in the supplement file appendix 1.

2. Table 3 Analysis of Variance; best if the author can limit the decimal point to the two decimal point for standardization in statistic. Please follow journal requirement. If it is not stated, two decimal point is best used to indicate the statistic results.

Corrected as advised.

3. Paragraph for discussion (line 185 - 193) is not needed. Focus your discussion based on the result without stating facts that have been previously discussed earlier in the introduction section.

Deleted as advised.

4. The paper is lacking in critical recommendation on the issue, while the author is pushing for proposed contingency plan? what kind of contingency plan that should be proposed for the pandemic? This might add value to the policy maker. Thus the conclusion seemed lacking in providing concrete ending to what should be done to prevent/ address the issue.

Recommendations has been added to the conclusion section (Lines 254-260)

Reviewer #2

A well organized article. The ethical review for the research meets the required standards. The methods of statistical analysis used for the research were sound and the results of the 2 way ANOVA test supported the conclusion of the article. Enough data was provided in the article although it would have been easier to absorb/understand the provided data used for analysis (OPD waiting times in days and Elective OR utilization rates during Pre, early and post pandemic periods) if they were all included in a single table of data extraction. The sizes of figures 1-4 could be increased a bit to provide better visibility for the reader. The article was written intelligibly, with appropriate use of the English language although there unnecessary repetition of facts in the introduction and discussion sections eg ''To contain the spread of the COVID-19 disease, the Saudi government adopted the lockdown strategy''. Adequate explanation of the reasons for variation in the results/findings among the 3 hospitals were give in the discussion section with good interpretation of the findings. The limitations were addressed properly and the conclusion was brief and concise. In general, it was a very interesting and quite unique article as it aims to explore, compare and analyse the differences in pandemic effects on Key performance indicators in 3 hospitals providing very different types of medical care.

Thank you so much for your valuable comments.

The data used for analysis (OPD waiting times in days and Elective OR utilization rates during Pre, early and post pandemic periods) were all included in a supplemental file.

The figures have been increased in size for better visibility.

Also, the unnecessary repetition of facts in the discussion section has been deleted.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Nasser Hadal Alotaibi

27 Apr 2023

The Impact of COVID-19 Pandemic on Key Performance Indicators in Three Saudi Hospitals

PONE-D-22-26363R1

Dear Dr. Alharbi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nasser Hadal Alotaibi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Nasser Hadal Alotaibi

2 May 2023

PONE-D-22-26363R1

The Impact of COVID-19 Pandemic on Key Performance Indicators in Three Saudi Hospitals

Dear Dr. Alharbi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nasser Hadal Alotaibi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Total number of OPD and OR visits in each COVID-19 stage in each hospital.

    (DOCX)

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES